Brief: Cumberland Pharmaceuticals Reports First Quarter 2023 Financial Results & Company Update
09/05/2023 23:04
Cumberland Pharmaceuticals Inc CPIX.O :
* CUMBERLAND PHARMACEUTICALS REPORTS FIRST QUARTER 2023
FINANCIAL
RESULTS & COMPANY UPDATE
* CUMBERLAND PHARMACEUTICALS INC Q1 REVENUE $9.2 MILLION
* CUMBERLAND PHARMACEUTICALS INC Q1 EARNINGS PER SHARE $0.01
* CUMBERLAND PHARMACEUTICALS INC Q1 ADJUSTED EARNINGS PER
SHARE
$0.11
Source text for Eikon: ID:nPn7MF11ya
Further company coverage: CPIX.O
Recent news on Cumberland Pharmaceuticals
See all newsBrief: Cumberland Pharmaceuticals Announces Assist-Ssc Trial Top-Line Results
Cumberland Pharmaceuticals Q2 loss widens after Apotex transaction
Brief: Cumberland Pharmaceuticals Announces Special Dividend Of $1.50 Per Share
Cumberland Pharmaceuticals Q1 revenue up 5%; to sell FDA‑approved brands to Apotex for $100 mln
NASDAQ RESUMED AT 09:38 AM